Results 31 to 40 of about 2,600 (141)

Psychometric evaluation of the PROMIS parent proxy mobility item bank for use in Duchenne muscular dystrophy

Developmental Medicine &Child Neurology, Volume 67, Issue 7, Page 918-929, July 2025.
Abstract Aim To evaluate the psychometric properties and measurement quality of the Patient‐Reported Outcomes Measurement Information System Parent Proxy (PROMIS PP) Mobility item bank (v1.0, 23 items) for children with Duchenne muscular dystrophy (DMD), through Rasch statistical analysis. Method De‐identified PROMIS PP Mobility items were completed by
Linda Pax Lowes, Corinne M. Le Reun, Lindsay N. Alfano, Natalie F. Reash, Megan A. Iammarino, Shivangi Patel, Ivana F. Audhya   +6 more
wiley   +1 more source

medinfo quergelesen: Informationen aus dem Weblog medinfo (Januar-April 2008) / Skim through medinfo: Information from the medinfo weblog (January-April 2008)

GMS Medizin – Bibliothek – Information, 2008
Are you up to date? This article provides a selection of the most interesting contents of the weblog medinfo from January to April 2008.
Klein, Diana
doaj  

Defining Renal Recovery in Patients With Hepatorenal Syndrome‐Acute Kidney Injury: Experience From North American Studies

JGH Open, Volume 8, Issue 12, December 2024.
ABSTRACT Introduction The degree of improvement in serum creatinine (SCr) has previously been suggested as a sensitive indicator of treatment response in patients with hepatorenal syndrome‐acute kidney injury (HRS‐AKI), while HRS reversal remains the primary endpoint in clinical trials.
Muhammad A. Mujtaba, Hussien Elsiesy, Sara Faiz, Syed A. Hussain, Ann Kathleen N. Gamilla‐Crudo, Aftab Karim, Mohammad Irfan Khan, Muhammad Waqar Khattak, Zunaira Zafar, Michael Kueht, Khurram Jamil   +10 more
wiley   +1 more source

medinfo quergelesen: Informationen aus dem Weblog medinfo (Mai–Dezember 2008) / Skim through medinfo: Information from the medinfo weblog (May–December 2008)

GMS Medizin – Bibliothek – Information, 2008
Are you up to date? This article provides a selection of the most interesting contents of the weblog medinfo from May to December 2008.
Klein, Diana
doaj  

B cell and aquaporin‐4 antibody relationships with neuromyelitis optica spectrum disorder activity

Annals of Clinical and Translational Neurology, Volume 11, Issue 10, Page 2792-2798, October 2024.
Abstract This post hoc analysis of the randomized, placebo‐controlled N‐MOmentum study (NCT02200770) of inebilizumab in neuromyelitis optica spectrum disorder (NMOSD) evaluated relationships between circulating B‐cell subsets and aquaporin‐4 immunoglobulin G (AQP4‐lgG) titers and attacks.
Jeffrey L. Bennett, Sean J. Pittock, Friedemann Paul, Ho Jin Kim, Sarosh R. Irani, Kevin C. O'Connor, Kristina R. Patterson, Michael A. Smith, Michele Gunsior, Nanette Mittereder, William A. Rees, Daniel Cimbora, Bruce A. C. Cree   +12 more
wiley   +1 more source

medinfo quergelesen: Informationen aus dem Weblog medinfo (Januar–April 2009) / Skim through medinfo: Information from the medinfo weblog (January–April 2009)

GMS Medizin – Bibliothek – Information, 2009
Are you up to date? This article provides a selection of the most interesting contents of the weblog medinfo from January to April 2009.
Klein, Diana
doaj  

Referring quality assessment of primary health care for endocrinology in Rio Grande do Sul, Brazil [PDF]

, 2015
Telemedicin
Grendene, Grabriela Monteiro, Katz, Natan, Harzheim, Erno, Rodrigues, Átila Szczecinski   +3 more
core   +1 more source

Comparative analysis of real‐world adherence and persistence patterns with vibegron, mirabegron, and anticholinergics in patients with overactive bladder: A retrospective claims study

Neurourology and Urodynamics, Volume 43, Issue 7, Page 1504-1513, September 2024.
Abstract Introduction Vibegron is a selective β3‐adrenergic receptor agonist that was approved by the US Food and Drug Administration in December 2020 for the treatment of overactive bladder in adults. This retrospective study assessed US pharmacy claims data to evaluate the real‐world adherence and persistence of vibegron compared with mirabegron and ...
Benjamin Chastek, Adam Carrera, Christina Landis, Daniel Snyder, Laleh Abedinzadeh, Tim Bancroft, Jeffrey Nesheim, Michael Kennelly, David Staskin   +8 more
wiley   +1 more source

Pharmacological Interventions for Cirrhotic Ascites: From Challenges to Emerging Therapeutic Horizons

Gut and Liver
Ascites is the most common complication in patients with decompensated cirrhosis. This condition results in a severely impaired quality of life, excessive healthcare use, recurrent hospitalizations and significant morbidity and mortality.
Yuan Gao, Xin Liu, Yunyi Gao, Meili Duan, Bing Hou, Yu Chen   +5 more
doaj   +1 more source

Consistency management in multiple perspective medical decision analysis

, 1998
Medinfo.
Tze-Yun LEONG,, Zheng J.,, Leong, T.-Y., Zheng, J., Leong, T.Y.   +4 more
core   +1 more source